BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 31, 1998
View Archived Issues
Atrix: Q2 1998 highlights
Read More
Unimed's Androgel shows promising phase II results
Read More
AEterna announces positive phase I results with Neovastat
Read More
Research on alpha2-agonists continues at P&G
Read More
PLC Systems: Q2 1998 and six-month highlights
Read More
Affymetrix: Q2 1998 highlights
Read More
Results of phase II study support efficacy of (S)-fluoxetine as a treatment for migraine
Read More
Trimeris: Q2 1998 highlights
Read More
Nordic Drugs to distribute Xechem's paclitaxel products in Scandinavia
Read More
Matrix Pharmaceutical: Q2 1998 highlights
Read More
Antineoplastic phenanthridinium compounds discovered at Nippon Kayaku
Read More
Pfizer describes use of protein tyrosine kinase inhibitors to treat hyperproliferative disorders
Read More
Chronic nepicastat is an effective adjunct therapy for heart failure
Read More
Nicanartine as a possible preventive therapy following angioplasty in coronary artery disease
Read More
Orion and Novartis agree on the distribution of entacapone
Read More
Laboratorios INIBSA to distribute ImmunoCyt in Spain and Portugal
Read More
Columbia Laboratories develops hormone replacement tablet for men
Read More
New ACAT inhibitors synthesized at Sumitomo
Read More
Sustained-release angiopeptin therapy is well tolerated following coronary angioplasty
Read More
Highly active and stable new carbapenems described by Meiji Seika
Read More
Efficacy of etomoxir as a treatment for CHF demonstrated in clinical and preclinical studies
Read More
FDA grants first approval for an antisense drug
Read More
Canadian authorities approve use of Fragmin in treatment of heart disease
Read More
Vertex, Schering AG form strategic alliance to develop neurologic drugs
Read More
Thalidomide analogue inhibits tumor metastasis in melanoma-bearing mice
Read More
New treatment for osteoarthritis pain now available in the U.K.
Read More
Dual-action anti-HIV and spermicidal compounds reported by Hughes Institute
Read More